Genomic Valley Biotech share news, announcements and annual reports
BSE: 539206Pharmaceuticals & BiotechnologySmall Cap
GENOMIC VALLEY BIOTECH LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2015
Last close ₹45.81up ₹2.18 (5.00%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹43.63.
29 Oct: open ₹45.81, high ₹45.81, low ₹45.81
52-week range of traded prices to 29 Oct 2026
₹20.10Low, 29 Jan 2026₹45.81High, 29 Oct 2026
- Under BSE's graded surveillance, stage 0, and long-term additional surveillance, stage I, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 30 Oct 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14 Cr4,774th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 689.29
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 555
Genomic Valley Biotech board meetings
123 filed, newest first. Page 3 of 3.
Feb 2019
1 Feb · Board meeting
Meeting on 13 Feb 2019: quarterly results
Jan 2019
17 Jan · Board meeting
Meeting on 21 Jan 2019
Nov 2018
Aug 2018
May 2018
Feb 2018
Nov 2017
Sep 2017
Aug 2017
May 2017
Nov 2016
Sep 2016
Aug 2016
4 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 04, 2016, inter alia, has considered and approved the following: ....
May 2016
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has considered and approved the following: - ....
Apr 2016
30 Apr · Board meeting
Board of Directors of the Company at its meeting held on April 29, 2016, inter alia, has considered and approved the following: ....
Feb 2016
Jan 2016
11 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 11, 2016, inter alia, has considered and approved the following: ....
Aug 2015
7 Aug · Board meeting
Board of Directors of the Company at its August 07, 2015, inter alia, has considered and approved the following: - Taken note ....